ELAV-Like Protein 3/administration & dosageELAV-Like Protein 3/adverse effectsELAV-Like Protein 3/analysisELAV-Like Protein 3/antagonists & inhibitorsELAV-Like Protein 3/biosynthesisELAV-Like Protein 3/bloodELAV-Like Protein 3/cerebrospinal fluidELAV-Like Protein 3/chemical synthesisELAV-Like Protein 3/classificationELAV-Like Protein 3/deficiencyELAV-Like Protein 3/drug effectsELAV-Like Protein 3/economicsELAV-Like Protein 3/geneticsELAV-Like Protein 3/historyELAV-Like Protein 3/immunologyELAV-Like Protein 3/isolation & purificationELAV-Like Protein 3/metabolismELAV-Like Protein 3/pharmacokineticsELAV-Like Protein 3/pharmacologyELAV-Like Protein 3/physiologyELAV-Like Protein 3/poisoningELAV-Like Protein 3/radiation effectsELAV-Like Protein 3/standardsELAV-Like Protein 3/supply & distributionELAV-Like Protein 3/therapeutic useELAV-Like Protein 3/toxicityELAV-Like Protein 3/ultrastructureELAV-Like Protein 3/urineELAV-Like Protein 3/chemistryELAV-Like Protein 3/agonists
hasDescriptor
allowableQualifier
broaderDescriptor
dateCreated
2015-07-10
dateEstablished
2016-01-01
dateRevised
2015-11-23
historyNote
2016; use ELAV PROTEINS 2012-2015
@en
identifier
D000067778
preferredConcept
preferredTerm
previousIndexing
ELAV Proteins (2005-2015)
@en
publicMeSHNote
2016; see HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS 2012-2015
@en
label
ELAV-Like Protein 3
@en